Many transcripts belonging to these metabolic pathways have been previously identified in the context of intrauterine growth restriction, including AKT3, FASN, LDLR, NCOA2, PPARGC1A, SREBF2, THRSP, GYS1, IGF1R, LEPR and SCD [13]. Here, SREBF2 is linked to fetal growth restriction.